Correction to: Neoadjuvant Systemic Therapy (NAST) in patients with melanoma: surgical considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Author(s):
Akkooi, A.C.J. van; Hieken, T.J.; Burton, E.M.; Ariyan, C.; Ascierto, P.A.; Asero, S.V.M.A.; Blank, C.U.; Block, M.S.; Boland, G.M.; Caraco, C.; Chng, S.; Davidson, B.S.; Neto, J.P.D.; Faries, M.B.; Gershenwald, J.E.; Grunhagen, D.J.; Gyorki, D.E.; Han, D.L.; Hayes, A.J.; Houdt, W.J. van; Karakousis, G.C.; Klop, W.M.C.; Long, G.V.; Lowe, M.C.; Menzies, A.M.; Bagge, R.O.; Pennington, T.E.; Rutkowski, P.; Saw, R.P.M.; Scolyer, R.A.; Shannon, K.F.; Sondak, V.K.; Tawbi, H.; Testori, A.A.E.; Tetzlaff, M.T.; Thompson, J.F.; Zager, J.S.; Zuur, C.L.; Wargo, J.A.; Spillane, A.J.; Ross, M.I.; Int Neoadjuvant Melanoma Consortiu
Published
2022
Publication type
Article / Letter to editor
Date issued
2022-04-15
Language
English
Publisher
SPRINGER
Is part of
Annals of Surgical Oncology (2022), Vol. 29, no. 8, p. 5241-5242
hdl
1887/3589657
doi
10.1245/s10434-022-11622-0